Skip to main content
Clinical Trials/ACTRN12610001033033
ACTRN12610001033033
Withdrawn
未知

In Intensive Care patients receiving haemofiltration is the Niagara or the Dolphin vasocath model more effective in terms of ease of insertion, infection rate, filter life and time to device failure?

Kieran Hogan0 sites60 target enrollmentNovember 24, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
acute renal failure
Sponsor
Kieran Hogan
Enrollment
60
Status
Withdrawn
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 24, 2010
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kieran Hogan

Eligibility Criteria

Inclusion Criteria

  • Patients requiring haemofiltration for acute renal failure

Exclusion Criteria

  • Allergy to material of vascular device

Outcomes

Primary Outcomes

Not specified

Similar Trials